Le Lézard
Classified in: Health
Subjects: NPT, AVO

Stars Take the Fight to End Type 1 Diabetes to Capitol Hill for the 2023 JDRF Children's Congress


Celebrity Advocate Town Hall ? July 10, 9 a.m.

Senate Appropriations Committee Hearing ? July 11, 10 a.m.

Jimmy Jam, Member of the Rock & Roll Hall of Fame, and Type 1 Diabetes Parent to Testify at Senate Hearing

More than 1.4 million Americans live with type 1 diabetes, an autoimmune condition that causes the pancreas to make very little insulin or none at all

WASHINGTON, July 5, 2023 /PRNewswire/ -- JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to announce the lineup for the 2023 JDRF Children's Congress Celebrity Advocate Town Hall. The interactive event will feature questions from Children's Congress delegates, kids, and teens from across the U.S. and JDRF's affiliates in the United Kingdom, Australia, the Netherlands, and Canada, that live with T1D.The town hall will be held Monday, July 10 at the Marriott Marquis in Washington, D.C.  

JDRF 2023 Children's Congress Celebrity Advocates

What: The 2023 JDRF Children's Congress Celebrity Advocate Town Hall
Who: JDRF, Aaron Kowalski, Ph.D., JDRF CEO, accomplished individuals in sports, entertainment, fashion, and media, who are living with T1D or have a loved one with the disease. Adam Schefter of ESPN will serve as moderator. 
When: Monday, July 10 at 9 a.m.
Where: The Marriott Marquis Washington DC, 901 Massachusetts Ave NW, Washington, D.C 20001, Independence Ballroom

Tuesday, July 11, Jimmy Jam, award-winning producer, songwriter, and member of the Rock & Roll Hall of Fame will testify during a Senate Appropriations Committee hearing to encourage Congress to renew the Special Diabetes Program and advocate for policies to ensure insulin is available at an affordable and predictable price. He will be joined by Aaron Kowalski, Ph.D., JDRF CEO, Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, and more than 160 JDRF Children's Congress delegates. The youth delegates will travel to Washington D.C. from across the U.S. and JDRF's international affiliates in the United Kingdom, Australia, the Netherlands, and Canada.

What: Jimmy Jam, member of the Rock & Roll Hall of Fame, and type 1 diabetes parent to testify at Senate hearing in support of the Special Diabetes Program and insulin affordability 
Who: JDRF, Jimmy Jam, Aaron Kowalski, Ph.D., JDRF CEO, Dr. Griffin Rodgers, NIH, Senator Susan Collins, Senator Jeanne Shaheen, Senator Patty Murray, members of the U.S. Senate Committee on Appropriations, youth living with type 1 diabetes and their families 
When: Tuesday, July 11 at 10 a.m.
Where: The Dirksen Senate Office Building, 50 Constitution Ave NE, Washington, DC 20002, Room 106

SOURCE JDRF


These press releases may also interest you

at 05:05
Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland. The Sun Nuclear booth (#930) will highlight demonstrations and insights on the...

at 04:32
According to the latest BCC...

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...



News published on and distributed by: